Rossari Biotech Limited Stock Current Valuation
| ROSSARI Stock | 826.15 18.40 2.18% |
Valuation analysis of Rossari Biotech helps investors to measure Rossari Biotech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, Rossari Biotech's Total Cash From Operating Activities is increasing as compared to previous years. The Rossari Biotech's current End Period Cash Flow is estimated to increase to about 254.9 M, while Change In Cash is forecasted to increase to (418.3 M). Fundamental drivers impacting Rossari Biotech's valuation include:
Price Book 4.0917 | Enterprise Value 46.5 B | Enterprise Value Ebitda 17.5089 | Price Sales 2.3764 | Trailing PE 33.0064 |
Overvalued
Today
Please note that Rossari Biotech's price fluctuation is very steady at this time. Calculation of the real value of Rossari Biotech is based on 3 months time horizon. Increasing Rossari Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Rossari Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rossari Stock. However, Rossari Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 826.15 | Real 619.61 | Hype 835.38 | Naive 844.76 |
The intrinsic value of Rossari Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Rossari Biotech's stock price.
Estimating the potential upside or downside of Rossari Biotech Limited helps investors to forecast how Rossari stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rossari Biotech more accurately as focusing exclusively on Rossari Biotech's fundamentals will not take into account other important factors: Rossari Biotech Limited Company Current Valuation Analysis
Rossari Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Rossari Biotech Current Valuation | 46.49 B |
Most of Rossari Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rossari Biotech Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Rossari Biotech Limited has a Current Valuation of 46.49 B. This is 307.5% higher than that of the Chemicals sector and 50.91% higher than that of the Materials industry. The current valuation for all India stocks is 179.67% lower than that of the firm.
Rossari Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rossari Biotech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rossari Biotech could also be used in its relative valuation, which is a method of valuing Rossari Biotech by comparing valuation metrics of similar companies.Rossari Biotech is currently under evaluation in current valuation category among its peers.
Rossari Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0735 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 46.49 B | ||||
| Shares Outstanding | 55.36 M | ||||
| Shares Owned By Insiders | 68.18 % | ||||
| Shares Owned By Institutions | 19.03 % | ||||
| Price To Book | 4.09 X | ||||
| Price To Sales | 2.38 X | ||||
| Revenue | 18.31 B | ||||
| Gross Profit | 3.74 B | ||||
| EBITDA | 2.57 B | ||||
| Net Income | 1.31 B | ||||
| Total Debt | 1.19 B | ||||
| Book Value Per Share | 202.14 X | ||||
| Cash Flow From Operations | 432.55 M | ||||
| Earnings Per Share | 25.03 X | ||||
| Target Price | 988.25 | ||||
| Number Of Employees | 450 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 45.73 B | ||||
| Total Asset | 15.72 B | ||||
| Retained Earnings | 5.65 B | ||||
| Working Capital | 4.2 B | ||||
| Annual Yield | 0.0006 % | ||||
| Net Asset | 15.72 B |
About Rossari Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rossari Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rossari Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rossari Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rossari Stock
Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.